Tunbridge Wells Hospital Pembury
Royal Tunbridge Wells, United Kingdom
NCT Number: NCT07796165
Case series of infants with anterior ankyloglossia being treated by the Sublingual Neonatal Incision Platform device
Trial opening soon.
Get Notified1 week–12 week
All sexes
Interventional
Not applicable
Royal Tunbridge Wells, United Kingdom
A study assessing the feasibility of a novel device designed specifically to treat infant tongue-tie.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient treated using the novel device under study
Other names: Treatment with SNIP device
Time frame: Immediately post-op
The physician will be asked to rate following attributes of the use of the tool, in Likert scale of 1-5; Whether the device felt intuitive, whether they felt more confident using this device, whether they would use this device again for a similar release?
Time frame: Immediately post-op
The physician will be asked to rate Operator-perceived infant discomfort in Likert scale of 1-10
Trial opening soon.
Get NotifiedEuropa Life Sciences Limited
Industry
SNIP 2 Case Series
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07757503
Ankyloglossia, Behavior
Guadalajara, Spain
View Trial DetailsNCT07719582
Ankyloglossia, Impairment of Speech
Naples, Florida, United States
View Trial DetailsNCT06856564
Ankyloglossia, Stomatognathic Diseases
Hanoi, Vietnam
View Trial DetailsNCT07110948
Ankyloglossia, Stomatognathic Diseases
Edmonton, Canada
View Trial Details